Vyant Bio Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
VYNT Over the counter 8731 https://www.vyantbio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Vyant Bio Inc

Vyant Bio Announces Last Day of Trading on Nasdaq and Filing of Form 15 for Voluntary Nasdaq Delisting and SEC Deregistration - May 12th, 2023 12:00 pm
Vyant Bio Announces Filing of Form 25 for Voluntary Nasdaq Delisting and SEC Deregistration - May 4th, 2023 8:30 pm
Vyant Bio Announces Voluntary Nasdaq Delisting and SEC Deregistration - Apr 24th, 2023 8:50 pm
Two top executives step down as Vyant Bio continues to explore strategic alternatives - Feb 6th, 2023 6:14 pm
VYNT: Withdrawing Valuation - Feb 3rd, 2023 12:12 pm
Vyant Bio Commences a Cash Preservation Plan Including a Reduction in Force - Feb 3rd, 2023 11:00 am
VYNT: Predicting Drug Discovery - Jan 30th, 2023 10:55 am
Vyant Bio Engages LifeSci Capital to Explore Strategic Alternatives - Jan 4th, 2023 9:15 pm
Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at Neuroscience 2022 Hosted by the Society for Neuroscience - Nov 16th, 2022 10:05 pm
Vyant Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement - Nov 16th, 2022 9:43 pm
Vyant Bio Reports Third Quarter 2022 Results and Provides Strategic and Business Highlights - Nov 15th, 2022 1:00 pm
Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at the 2022 CDKL5 Forum Hosted by the Loulou Foundation - Nov 10th, 2022 10:13 pm
Vyant Bio to Participate at Neuroscience 2022, the 52nd Annual Gathering of the Society for Neuroscience, on November 12-16 - Nov 10th, 2022 1:00 pm
Vyant Bio Teams Up with the International Rett Syndrome Foundation to Host Local Viewing Party in Honor of the 3rd Annual ‘Raise a Glass for Rett Gala’ - Nov 7th, 2022 2:00 pm
Reaction Biology and Vyant Bio Announce Closing of Definitive Agreement to Acquire U.S. Operations of Vyant Bio, Inc. Subsidiary - Nov 3rd, 2022 1:10 pm
Vyant Bio Announces One-for-Five Reverse Stock Split - Nov 1st, 2022 12:00 pm
Vyant Bio Announces Participation at the 2022 CDKL5 Forum Hosted by the Loulou Foundation on November 7-8, 2022 - Oct 27th, 2022 9:10 pm
Vyant Bio to Present at the LD Micro Main Event XV on Wednesday, October 26, 2022 - Oct 24th, 2022 8:15 pm
Vyant Bio to Deliver a Live Presentation at the Skyline Signature Series™ on Thursday, September 8, 2022 - Sep 1st, 2022 12:00 pm
Vyant Bio to Present at the H.C. Wainwright 24th Annual Global Investment Conference - Aug 31st, 2022 12:00 pm